Linkage of CD40L to a self-tumor antigen enhances the antitumor immune responses of dendritic cell-based treatment |
| |
Authors: | Hsin-Wei Chen Hsing-I Huang Yi-Ping Lee Li-Li Chen Hsiung-Kun Liu Mei-Lien Cheng Jy-Ping Tsai Mi-Hua Tao Chou-Chik Ting |
| |
Affiliation: | Immunology Group, National Health Research Institutes, Taipei, Taiwan. |
| |
Abstract: | CD40-CD40 ligand (CD40L) interaction is an important costimulatory signal in the interaction between T cells and antigen-presenting cells (APC). In the present study, we determined whether the linkage of CD40L to the tumor-specific idiotype (Id) derived from a murine B-cell lymphoma, 38C13, could enhance its immunogenicity when presented by dendritic cells (DC). We showed that bone marrow-derived DC pulsed with Id-CD40L upregulated the expression of CD40, CD80, CD86, and major histocompatibility complex (MHC) class II molecules with the increased production of interleukin-12 (IL-12). Mice immunized with DC loaded with Id-CD40L showed high levels of anti-Id antibody response of both IgG2a and IgG1 isotypes. In addition, nylon wool-enriched T cells from these immunized mice showed a tumor-specific T-cell proliferative response upon stimulation with Id protein. Mice immunized with DC pulsed with Id alone failed to show any of these immune responses. Immunization with DC pulsed with Id-CD40L showed increased resistance to the challenge by 38C13 tumor, and tumor growth was significantly retarded. Together, these results show that linkage of CD40L to a self-tumor antigen enhances the anti-tumor immune response in DC-based treatment. |
| |
Keywords: | |
本文献已被 PubMed SpringerLink 等数据库收录! |
|